González Zorn, Bruno2026-01-152026-01-152021Gonzalez-Zorn B. (2021). Antibiotic use in the COVID-19 crisis in Spain. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(4), 646–647. https://doi.org/10.1016/j.cmi.2020.09.0551198-743X10.1016/j.cmi.2020.09.055https://hdl.handle.net/20.500.14352/130350Before the coronavirus disease 2019 (COVID-19) pandemic, antimicrobial resistance was the world`s most pressing health crisis. The United Nations, the World Health Organization (WHO) and the European Center for Disease Control and Prevention have made antimicrobial resistance a top priority, establishing a task force in the G-20 and organizing a joint program initiative on antimicrobial resistance including countries from al over the world [1]. However, with the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus pandemic in January 2020, all efforts are now focused on COVID-19, including controlling infections and developing vaccinesengAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/journal article1469-0691https://doi.org/10.1016/j.cmi.2020.09.05533248926open access636.09AntibioticsConsumptionCOVID-19HospitalsSARS-CoV-2Veterinaria3109 Ciencias Veterinarias